HistoSonics - About the company
HistoSonics is an acquired company based in Ann Arbor (United States), founded in 2009 by Thomas Davison, Jim Bertolina and Christine Gibbons. It operates as an Ultrasound-based tissue ablation. HistoSonics has raised $566M in funding from investors like Venture Investors, Early Stage Partners and Hatteras Venture Partners, with last known valuation of $*****. The company has 11 active competitors, including 2 funded and 1 that has exited. Its top competitors include companies like Sound Blade Medical, SONIRE Therapeutics and Haifu Medical.
Company Details
HistoSonics is developing Histotripsy technology, licensed from the University of Michigan. It is a non-invasive, image guided therapeutic ultrasound system that excises tissue. Uses pulsed sound waves to induce cavitation that mechanically destroys tissue, tumors and plaque at the cellular level. Application areas include cardiovascular, oncology, neurology and urology.
- Website
- histosonics.com
- Social
- Email ID
- *****@histosonics.com
- Registered Address
- Plymouth, Minnesota
Key Metrics
Founded Year
2009
Location
Ann Arbor, United States
Stage
Acquired
Total Funding
$566M in 12 rounds
Latest Funding Round
Last Known Valuation
$***** as on Aug 01, 2024
Investors
Ranked
1st among 11 active competitors
Employee Count
420 as on Jun 30, 2026
Similar Companies
Exit Details
Acquired by K5 Global (Aug 07, 2025)
Legal entities associated with HistoSonics
HistoSonics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Histosonics, Inc Attn Christine CIN: 271236963 , United States, Active | Dec 31, 1999 | - | 198 (As on Dec 31, 2024) | - |
HistoSonics's acquisition details
Click here to take a look at HistoSonics's acquisition in detail
Sign up to download HistoSonics' company profile
HistoSonics's funding and investors
HistoSonics has raised a total funding of $566M over 12 rounds. Its first funding round was on Dec 16, 2009. Its latest funding round was a Series E round on Jun 22, 2026 for $*****. 2 investors participated in its latest round. HistoSonics has 25 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of HistoSonics:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 22, 2026 | 7163130 | Series E | 2842999 | 2586261 | 7815867 | 2380141 |
Oct 16, 2025 | 1809452 | Series E | 6002373 | 7758036 | 3915272 | |
Jul 31, 2024 | 2277651 | Series D | 4725577 | 4218751 |
Access funding benchmarks and valuations. Sign up today!View details of HistoSonics's funding rounds and investors
HistoSonics' founders and board of directors
Founder? Claim ProfileHere are the details of HistoSonics' key team members:
- Thomas Davison: Co-Founder - Advisor of HistoSonics. They serve on the board of 1 company.
- Jim Bertolina: Former Co-Founder of HistoSonics.
- Christine Gibbons: Former Co-Founder of HistoSonics.
View details of HistoSonics's Founder profiles and Board Members
HistoSonics' employee count trend
HistoSonics has 420 employees as of Jun 26. Here is HistoSonics's employee count trend over the years:
Uncover HistoSonics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
HistoSonics's Competitors and alternates
Top competitors of HistoSonics include Sound Blade Medical, SONIRE Therapeutics and Haifu Medical. Here is the list of Top 10 competitors of HistoSonics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | HistoSonics 2009, Ann Arbor (United States), Acquired | Ultrasound-based tissue ablation | $566M | 63/100 | |
2nd | Sound Blade Medical 2023, Halifax (Canada), Series A | Developer of a compact ultrasound therapy platform for non-invasive treatment of various pathologies | $16.5M | 56/100 | |
3rd |  SONIRE Therapeutics 2020, Tokyo (Japan), Series B | Developer of high intensity focused ultrasound treatment systems | $41.6M | 54/100 | |
4th | Haifu Medical 1999, Chongqing (China), Unfunded | High intensity focused ultrasound technology for tumor ablation | - | - | 28/100 |
5th | Elbe Valley Medical 2017, Mullingar (Ireland), Unfunded | Developer of medical device to treat metastatic cancer tumors | - | - | 28/100 |
6th | Developer of non-invasive ultrasound cancer therapies | - | - | 26/100 | |
7th | Acoustic Medsystems 2000, Savoy (United States), Funding Raised | Image-guided therapeutic ultrasound devices for localized soft tissue diseases and pain | - | 25/100 | |
8th | Shanghai A & S Technology Development 2000, Zhangjiagang (China), Unfunded | High-Intensity Focused Ultrasound Devices | - | - | 24/100 |
9th | Image Guided Therapy 2001, Pessac (France), Funding Raised | Develops devices for the treatment of cancer | - | 22/100 | |
10th | Shenzen Promethe Medical Sci-Tech 2003, Shenzhen (China), Unfunded | High Intensity Focused Ultrasound Devices | - | - | 18/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on HistoSonics's competitors? Click here to see the top ones
HistoSonics's Investments and acquisitions
HistoSonics has made no investments or acquisitions yet.
Reports related to HistoSonics
Here is the latest report on HistoSonics's geography:
News related to HistoSonics
Filter this listMedia has covered HistoSonics for a total of 27 events in the last 1 year, 8 of them have been about company updates and 1 about partnerships.
•
•
HistoSonics Edison Histotripsy System Receives CE Mark ApprovalMedical Product Outsourcing•Jul 13, 2026•HistoSonics
•
•
HistoSonics Secures Financing from Yosemite and Other Investors, Valued at $3.75 BillionKorea Newswire•Jun 23, 2026•HistoSonics
•
HistoSonics receives major TFDA approval in Taiwan, accelerating global expansionBusiness Wire•May 18, 2026•HistoSonics
•
HistoSonics submits De Novo request to FDA for kidney tumor treatment with Edison Histotripsy SystemBusinessFortNight•May 11, 2026•HistoSonics
•
•
HistoSonics Treats First Patients with Edison System for BPHBusinessFortNight•Mar 30, 2026•HistoSonics
•
•
Synektik signs agreement with US-based HistoSonics to distribute cancer therapy equipmentgospodarka.sos.pl•Jan 08, 2026•Synektik, HistoSonics
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about HistoSonics
Explore our recently published companies
- Wisdom Square Technologies - New Hyde Park based, 2008 founded, Unfunded company
- Fruverpack - Almoradi based, 1992 founded, Unfunded company
- AERA - Bouxwiller based, 1979 founded, Unfunded company
- Divine Hindu - Ujjain based, 2023 founded, Unfunded company
- Globaldigitalpartner.com - 2013 founded, Unfunded company
- OROK - Bourgoin Jallieu based, 2018 founded, Deadpooled company
